Arformoterol 15mcg/2ml Inh 60 X 2ml

Manufacturer TEVA PHARMACEUTICALS USA Active Ingredient Arformoterol(ar for MOE ter ol) Pronunciation ar for MOE ter ol
It is used to treat COPD (chronic obstructive pulmonary disease).Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
🏷️
Drug Class
Bronchodilator
🧬
Pharmacologic Class
Long-acting beta2-adrenergic agonist (LABA)
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Oct 2006
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Arformoterol is a medicine used to help people with chronic obstructive pulmonary disease (COPD) breathe easier. It works by relaxing the muscles around the airways in your lungs, making them wider. This medicine is taken twice a day using a nebulizer and is for long-term use, not for sudden breathing problems.
πŸ“‹

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only, using a special machine called a nebulizer, which delivers the medication directly into your lungs.

Important Usage Instructions

Continue using this medication as directed by your doctor or healthcare provider, even if you start feeling better.
Do not swallow this medication.
Do not inject this medication.
Use only the type of nebulizer recommended by your doctor. If you're unsure, consult with your doctor.
Each vial is for single use only; discard any unused portion after administering the dose.
Do not open the vial until you're ready to use it.
Do not mix any other medications with this one in the nebulizer.
Check the solution before use; do not use if it appears cloudy, is leaking, has particles, or has changed color.

Storage and Disposal

Store this medication in the refrigerator; do not freeze.
Keep unused containers in their foil pouches until use.

What to Do If You Miss a Dose

If you miss a dose, skip it and return to your regular schedule.
Do not take two doses at the same time or take extra doses.
πŸ’‘

Lifestyle & Tips

  • Do not use arformoterol for sudden breathing problems; always carry a fast-acting rescue inhaler (e.g., albuterol) for acute symptoms.
  • Use arformoterol regularly, twice a day, even if you feel better, to maintain its effect.
  • Do not exceed the prescribed dose or frequency.
  • Avoid smoking and exposure to lung irritants.
  • Follow your doctor's instructions for other COPD medications.
  • Report any worsening of breathing or increased use of your rescue inhaler to your doctor immediately.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 15 mcg (2 mL) administered twice daily (morning and evening) by nebulization.
Dose Range: 15 - 15 mg

Condition-Specific Dosing:

COPD Maintenance: 15 mcg (2 mL) via nebulizer twice daily, approximately 12 hours apart.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary.
Moderate: No dosage adjustment necessary.
Severe: No dosage adjustment necessary.
Dialysis: No specific recommendations; use with caution due to limited data.

Hepatic Impairment:

Mild: No dosage adjustment necessary.
Moderate: No dosage adjustment necessary.
Severe: Use with caution; no specific dosage recommendations due to limited data. Monitor for adverse effects.
Confidence: Medium

Pharmacology

πŸ”¬

Mechanism of Action

Arformoterol is a long-acting beta2-adrenergic agonist (LABA). It selectively stimulates beta2-adrenergic receptors in the lungs, leading to relaxation of bronchial smooth muscle and bronchodilation. This action is mediated by the activation of adenyl cyclase, which catalyzes the conversion of ATP to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP levels lead to activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in smooth muscle relaxation.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Not available (administered via inhalation, local action)
Tmax: Approximately 0.5-1 hour (plasma concentration)
FoodEffect: Not applicable (inhalation)

Distribution:

Vd: Not available
ProteinBinding: Approximately 52-65% (in vitro)
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 26 hours (terminal half-life)
Clearance: Not available
ExcretionRoute: Primarily urine (63-69%), feces (21-22%)
Unchanged: Approximately 1% (urine)
⏱️

Pharmacodynamics

OnsetOfAction: Within 7 minutes
PeakEffect: Approximately 1-3 hours
DurationOfAction: Approximately 12 hours
Confidence: Medium

Safety & Warnings

⚠️

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as arformoterol, increase the risk of asthma-related death. Arformoterol is not indicated for the treatment of asthma. Data from a large, placebo-controlled US study in asthma patients showed that LABAs may increase the risk of asthma-related death. This finding is considered a class effect of LABAs. The safety and efficacy of arformoterol in patients with asthma have not been established. Arformoterol is indicated only for the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD).
⚠️

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Signs of low potassium levels, such as:
+ Muscle pain or weakness
+ Muscle cramps
+ An abnormal heartbeat
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Signs of acidosis (too much acid in the blood), such as:
+ Confusion
+ Fast breathing
+ Fast heartbeat
+ An abnormal heartbeat
+ Severe stomach pain, upset stomach, or vomiting
+ Feeling very sleepy
+ Shortness of breath
+ Feeling very tired or weak
Chest pain or pressure
Fast heartbeat or abnormal heartbeat
Swelling in the legs or feet

Respiratory Problems: A Life-Threatening Condition

This medication can cause severe breathing problems, which may be life-threatening. If you experience trouble breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:

Back pain
Diarrhea
Stuffy nose
Flu-like symptoms
Dry mouth
Headache
Shakiness
Feeling nervous and excitable
Upset stomach
Feeling dizzy, tired, or weak
* Trouble sleeping

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening shortness of breath or wheezing
  • Chest pain or discomfort
  • Fast or irregular heartbeat (palpitations)
  • Severe headache
  • Tremor or nervousness
  • Muscle cramps
  • Signs of an allergic reaction (rash, hives, swelling of face/lips/tongue, difficulty breathing)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
If you have asthma, as this medication is not intended to treat this condition.
If you are currently using a similar medication. If you are unsure, consult your doctor or pharmacist to determine if the medications are similar.

This is not an exhaustive list of all potential interactions with this medication. Therefore, it is crucial to discuss the following with your doctor and pharmacist:

All prescription and over-the-counter medications you are taking
Any natural products or vitamins you are using
Your overall health and any existing medical conditions

To ensure your safety, carefully review all your medications and health conditions with your doctor before taking this medication. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. If you have diabetes (high blood sugar), be aware that this drug may occasionally increase your blood sugar levels. Consult with your doctor to discuss strategies for maintaining control over your blood sugar.

If you experience worsening breathing problems, a decrease in the effectiveness of your rescue inhaler, or an increased need to use your rescue inhaler, contact your doctor immediately. Do not exceed the prescribed dose or frequency of this medication, as overdoses of this type of drug have been fatal. Consult with your doctor if you have any concerns.

Medications like this one may increase the risk of asthma-related deaths in individuals with asthma who are not also using an inhaled steroid. However, this risk does not appear to apply to people with Chronic Obstructive Pulmonary Disease (COPD). If you have questions or concerns, discuss them with your doctor.

If you are 65 years or older, exercise caution when using this medication, as you may be more susceptible to side effects. If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor to discuss the potential benefits and risks to both you and your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Tachycardia (fast heart rate)
  • Arrhythmias (irregular heartbeat)
  • Palpitations
  • Myocardial ischemia (chest pain)
  • Hypertension or hypotension
  • Tremor
  • Nervousness
  • Headache
  • Nausea
  • Dizziness
  • Fatigue
  • Malaise
  • Hypokalemia (low potassium)
  • Hyperglycemia (high blood sugar)
  • Metabolic acidosis

What to Do:

Seek immediate medical attention. Treatment is supportive and symptomatic. Consider judicious use of a cardioselective beta-blocker, but only with extreme caution in patients with a history of bronchospasm. Call 1-800-222-1222 (Poison Control).

Drug Interactions

🚫

Contraindicated Interactions

  • Other long-acting beta2-adrenergic agonists (LABAs)
  • Beta-blockers (non-selective, e.g., propranolol, carvedilol)
πŸ”΄

Major Interactions

  • Monoamine oxidase inhibitors (MAOIs) (e.g., phenelzine, selegiline)
  • Tricyclic antidepressants (TCAs) (e.g., amitriptyline, imipramine)
  • QTc-prolonging drugs (e.g., quinidine, sotalol, macrolide antibiotics, antipsychotics)
  • Diuretics (non-potassium sparing, e.g., furosemide, hydrochlorothiazide)
🟑

Moderate Interactions

  • Sympathomimetics (e.g., pseudoephedrine, epinephrine)
  • Xanthine derivatives (e.g., theophylline)
  • Corticosteroids (systemic)
  • Non-potassium sparing diuretics
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary function tests (FEV1)

Rationale: To assess baseline lung function and severity of COPD.

Timing: Prior to initiation of therapy.

Cardiovascular assessment (ECG, blood pressure, heart rate)

Rationale: To identify pre-existing cardiovascular conditions due to potential adrenergic effects.

Timing: Prior to initiation of therapy.

Serum potassium

Rationale: To establish baseline, as beta2-agonists can cause hypokalemia.

Timing: Prior to initiation of therapy, especially in patients at risk.

Blood glucose

Rationale: To establish baseline, as beta2-agonists can cause hyperglycemia.

Timing: Prior to initiation of therapy, especially in diabetic patients.

πŸ“Š

Routine Monitoring

Signs and symptoms of worsening COPD or acute exacerbations

Frequency: Regularly, at each visit

Target: Stable symptoms, no increase in rescue inhaler use

Action Threshold: Increased shortness of breath, increased cough, increased sputum, increased rescue inhaler use; consider alternative or additional therapy.

Cardiovascular parameters (heart rate, blood pressure, ECG if indicated)

Frequency: Periodically, or if symptoms arise

Target: Within normal limits for patient

Action Threshold: Significant tachycardia, palpitations, arrhythmias, or hypertension; consider dose adjustment or discontinuation.

Serum potassium

Frequency: Periodically, especially in patients at risk or on concomitant diuretics

Target: 3.5-5.0 mEq/L

Action Threshold: Hypokalemia (<3.5 mEq/L); consider supplementation or alternative therapy.

Blood glucose

Frequency: Periodically, especially in diabetic patients

Target: Individualized glycemic targets

Action Threshold: Significant hyperglycemia; adjust diabetes management.

πŸ‘οΈ

Symptom Monitoring

  • Worsening shortness of breath
  • Increased cough
  • Increased sputum production
  • Increased use of rescue inhaler
  • Chest pain or discomfort
  • Palpitations
  • Tremor
  • Nervousness
  • Muscle cramps

Special Patient Groups

🀰

Pregnancy

Category C. There are no adequate and well-controlled studies of arformoterol in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Beta2-agonists may interfere with uterine contractility.

Trimester-Specific Risks:

First Trimester: Potential for developmental effects, but human data are limited.
Second Trimester: Potential for developmental effects, but human data are limited.
Third Trimester: Potential for interference with uterine contractility and transient metabolic effects (e.g., hyperglycemia, hypokalemia) in the mother and fetus.
🀱

Lactation

It is not known whether arformoterol is excreted in human milk. Caution should be exercised when arformoterol is administered to a nursing woman. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for arformoterol and any potential adverse effects on the breastfed infant from arformoterol or from the underlying maternal condition.

Infant Risk: Low to unknown. Potential for beta-adrenergic effects (e.g., irritability, tremor, increased heart rate) in the infant, though systemic absorption is low.
πŸ‘Ά

Pediatric Use

Safety and effectiveness in pediatric patients (under 18 years of age) have not been established. Arformoterol is not indicated for use in children.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, caution should be exercised in elderly patients due to the greater frequency of decreased hepatic, renal, or cardiac function, and concomitant disease or other drug therapy.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Arformoterol is a maintenance bronchodilator for COPD; it is NOT a rescue medication for acute bronchospasm.
  • Patients should always have a short-acting beta2-agonist (SABA) available for acute symptoms.
  • The black box warning for LABAs regarding asthma-related death applies to the class, even though arformoterol is indicated only for COPD.
  • Administer twice daily, approximately 12 hours apart, using a nebulizer.
  • Monitor for cardiovascular adverse effects (tachycardia, palpitations, hypertension) and metabolic effects (hypokalemia, hyperglycemia), especially in susceptible patients.
  • Avoid concomitant use with other LABAs or non-selective beta-blockers.
πŸ”„

Alternative Therapies

  • Other LABAs (e.g., formoterol, salmeterol, indacaterol, olodaterol, vilanterol)
  • Long-acting muscarinic antagonists (LAMAs) (e.g., tiotropium, aclidinium, glycopyrronium, umeclidinium)
  • Short-acting beta2-agonists (SABAs) for rescue (e.g., albuterol, levalbuterol)
  • Short-acting muscarinic antagonists (SAMAs) for rescue (e.g., ipratropium)
  • Methylxanthines (e.g., theophylline) - less commonly used due to narrow therapeutic index.
πŸ’°

Cost & Coverage

Average Cost: $300 - $600 per 60 x 2ml vials
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (preferred or non-preferred brand/generic)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the overdose, including the medication taken, the amount, and the time it occurred.